Particle for the encapsidation of a genome engineering system
AssigneeFlash Therapeutics
InventorsPascale Bouille, Régis Gayon, Lucille Lamouroux, Alexandra Iche
Life of this patent
Estimating the term…
Loading patent…
AssigneeFlash Therapeutics
InventorsPascale Bouille, Régis Gayon, Lucille Lamouroux, Alexandra Iche
Estimating the term…
The present invention relates to a retroviral particle comprising a protein derived from the Gag polyprotein, an envelope protein, optionally an integrase and at least two encapsidated non-viral RNAs, the encapsidated non-viral RNAs each comprising an RNA sequence of interest bound to an encapsidation sequence, each encapsidation sequence being recognized by a binding domain introduced into the protein derived from the Gag polyprotein and/or into the integrase, and at least one of said sequences of interest of the encapsidated non-viral RNAs comprises a part coding a nuclease.
A retroviral particle, comprising a protein derived from the Gag polyprotein, an envelope protein, optionally an integrase, and at least two encapsidated non-viral RNAs, the encapsidated non-viral RNAs each comprising an RNA sequence of interest bound to an encapsidation sequence, each encapsidation sequence being recognized by a heterologous binding domain introduced into the protein derived from the Gag polyprotein and/or into the integrase, in which the at least two encapsidated non-viral RNAs differ by their sequence of interest, wherein:
Dependencies are inferred from the claim text.